IRONWOOD PHARMACEUTICALS INC - 10-Q Filing
Ironwood Pharmaceuticals reports Q3 2026 financial results including royalty income from AbbVie collaborative arrangements and updates on convertible senior notes.
Tickers: $IRWD
Ironwood Pharmaceuticals reports Q3 2026 financial results including royalty income from AbbVie collaborative arrangements and updates on convertible senior notes.
Tickers: $IRWD